Data di Pubblicazione:
2020
Abstract:
COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
IBD; epidemiology; Age Factors; Betacoronavirus; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunosuppressive Agents; Italy; Male; Middle Aged; Outcome and Process Assessment, Health Care; Patient Acuity; Prospective Studies; Risk Factors; SARS-CoV-2; Coronavirus Infections; Inflammatory Bowel Diseases; Pandemics; Patient Care Management; Pneumonia, Viral
Elenco autori:
Bezzio, Cristina; Saibeni, Simone; Variola, Angela; Allocca, Mariangela; Massari, Alessandro; Gerardi, Viviana; Casini, Valentina; Ricci, Chiara; Zingone, Fabiana; Amato, Arnaldo; Caprioli, Flavio; Lenti, Marco Vincenzo; Viganò, Chiara; Ascolani, Marta; Bossa, Fabrizio; Castiglione, Fabiana; Cortelezzi, Claudio; Grossi, Laurino; Milla, Monica; Morganti, Daniela; Pastorelli, Luca; Ribaldone, Davide Giuseppe; Sartini, Alessandro; Soriano, Alessandra; Manes, Gianpiero; Danese, Silvio; Fantini, Massimo Claudio; Armuzzi, Alessandro; Daperno, Marco; Fiorino, Gionata
Link alla scheda completa:
Link al Full Text:
Pubblicato in: